Amazon has access to NHS data under contract

Amazon has free access to the healthcare information collected by the U.K.’s National Health Service (NHS) under the terms of a government contract, The Guardian revealed. The information could potentially give Amazon a huge leg up to develop, advertise and sell its own products.

In July, Amazon and NHS revealed that the tech giant’s voice-controlled tool, Alexa, would be leveraged to provide helpful healthcare information to users in the U.K., such as answering a question like, “What are the symptoms of the flu?”

The report comes at a time when patient privacy concerns are gaining attention and scrutiny as major technology companies partner with healthcare companies. For example, Google’s deal with Ascension Health, the nation’s largest Catholic health system, has come under fire for giving Google access to the health information of tens of millions of Ascension patients.

New information received by The Guardian found that Amazon was allowed to access other NHS information that it can use to make new products and benefit financially. In addition, Amazon can also share the information with third parties, The Guardian reported.

According to NHS, the contract does not allow patient data to be shared with Amazon. Amazon also said the information it can collect is already publicly available on the NHS website.

See the full story below:

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it. 

The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%. 

HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.